Source: Healio Coverage
January 13, 2022
1 min read
Save

Top in hem/onc: High-fiber diet benefits, smoking cessation after lung cancer diagnosis

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers reported that every 5-g increase in daily fiber intake correlated with a nearly 30% lower risk for disease progression or death among patients with melanoma who were treated with immune checkpoint inhibitors.

According to the data, the most pronounced benefit was among patients who did not take commercially available probiotic supplements. A review of the findings was the top story in hematology/oncology last week.

Fiber-rich foods
Source: Adobe Stock

Another top story explored the survival benefit of smoking cessation in patients with lung cancer.

Read these and more top stories in hematology/oncology below:

High-fiber diet linked to immunotherapy response among patients with melanoma

A high-fiber diet appeared to be associated with increased progression-free survival among patients with melanoma who started treatment with immune checkpoint inhibitors, according to study results published in Science. Read more.

Smoking cessation after lung cancer diagnosis linked to nearly 30% improvement in survival

Quitting smoking at or around time of diagnosis conferred a significant survival benefit for patients with lung cancer, according to results of a meta-analysis published in Journal of Thoracic Oncology. Read more.

Using trusts to shield assets: What to know about these key protection tools

Physicians interested in estate or asset protection planning inevitably inquire about the use of trusts. Certainly, trusts can play significant roles in many physicians’ estate and/or asset protection planning. Read more.

COVID-19 vaccine booster dose benefits patients with cancer

Patients with cancer who had no measurable immune response following full COVID-19 vaccination had “excellent potentiation” after receiving a third, booster dose, according to results of a study in Cancer Cell. Read more.

Patients with cancer at high risk for death due to breakthrough COVID-19 infections

Fully vaccinated patients with cancer who developed breakthrough COVID-19 infections appeared at high risk for hospitalization and death, according to study results published in Annals of Oncology. Read more.